This trial is looking at a new way to screen for type 2 diabetes in women who are at high risk. The goal is to improve diagnostic strategies.
0 Primary · 6 Secondary · Reporting Duration: 10 day wear period starting at 0-4 days, 4-6 weeks, and 6 months after delivery
40 Total Participants · 1 Treatment Group
Primary Treatment: 2-hour 75-g oral glucose tolerance test and Dexcom G6 Pro continuous glucose monitor · No Placebo Group · N/A
Age 18 - 45 · Female Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
|18 - 65||100.0%|
|University of North Carolina at Chapel Hill||100.0%|
|Did not meet criteria||100.0%|